German chemical company Wacker has signed a contract with Danish biotech Biosyntia to develop a large-scale production process for biotin based on the fermentation of...
Up to now, the name BioNTech has popped up mostly in one breath with Pfizer, the company’s US partner in developing the mRNA-based Covid-19 vaccine marketed as Comirnaty...
Bayer will potentially pump well over $1 billion into another major gene therapy collaboration, this time with Brisbane, California-based Mammoth BioSciences. In the pact...
Germany’s Merck has signed a definitive agreement to acquire Exelead, a US biopharmaceutical CDMO, for around $780 million in cash. The Indianapolis, Indiana-based...
US biotech Amyris has formed a 50:50 joint venture with compatriot clinical-stage immunotherapy firm ImmunityBio to accelerate the commercialization of a next-generation...
Between the Christmas and the New Year’s bells and on both sides, the international pharmaceutical and healthcare sector continued battling the coronavirus pandemic. In...
US Army scientists working at the Walter Reed Army Institute of Research attached to the US military medical center of the same name have hinted at promising results from...
Following a strategic review of its Health division in April, Johnson Matthey (JM) has agreed to sell a majority stake in the business to US investment company Altaris...
Following a recommendation by the European Medicines Agency (EMA), the European Commission has granted conditional marketing authorization to the protein-based Covid-19...
With the fast rolling wave of yet another Coronavirus variant sparking global concern, vaccine mandates, booster shots and efficacy studies are dominating headlines in...